Puma Biotechnology (PBYI) Change in Account Payables (2011 - 2026)

Puma Biotechnology's Change in Account Payables history runs 16 years deep, the most recent figure standing at $3.1 million for Q1 2026.

• Quarterly Change in Account Payables rose 501.55% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 172.84% YoY) and the FY2025 annual result came in at -$453000.0, up 67.17% from the prior year.
• Change in Account Payables was $3.1 million for Q1 2026 at Puma Biotechnology, up from -$1.3 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $5.1 million in Q3 2022 and bottomed at -$8.5 million in Q4 2022.
• A 5-year average of -$176941.2 and a median of $517000.0 in 2025 frame the typical range for Change in Account Payables.
• Peak annual rise in Change in Account Payables reached 671.28% in 2024, while the deepest fall reached 209.41% in 2024.
• Puma Biotechnology's Change in Account Payables stood at -$8.5 million in 2022, then jumped by 121.54% to $1.8 million in 2023, then plunged by 209.41% to -$2.0 million in 2024, then soared by 33.5% to -$1.3 million in 2025, then soared by 333.83% to $3.1 million in 2026.
• Business Quant data shows PBYI's Change in Account Payables at $3.1 million in Q1 2026, -$1.3 million in Q4 2025, and $962000.0 in Q3 2025.